Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06633224 · ClinicalTrials.gov registry record
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
A clinical trial of Cancer and Head and Neck Cancer, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 125
- Enrollment target
- 1
- Study location
NCT06633224: Recruiting study of Cancer and Head and Neck Cancer, sponsored by University of California, San Francisco.
NCT06633224 is a study of Cancer and Head and Neck Cancer that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 125 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06633224, a study of Cancer and Head and Neck Cancer, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
Cancer-related fatigue (CRF) is a significant problem for cancer patients. This prospective, basic science, observational study will evaluate for changes in CRF associated with molecular characteristics prior to, during, and at the completion of non-investigational, standard-of-care, combined chemotherapy and radiation therapy (CCRT) and to develop and assess predictive models for CRF severity.
Primary Outcome
Association between phenotypic characteristics and initial levels and trajectories of CRF severity will be assessed using a hierarchical linear model (HLM) approach.
Conditions Studied
Interventions
- PROCEDURE Blood Specimen Collection
- OTHER Stool Specimen Collection
- OTHER Quality of Life (QOL) Questionnaires
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2024-12-27 |
| Est. Completion | 2027-09-01 |
What NCT06633224 shows while recruiting
NCT06633224 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower).
The record links to 5 conditions, with Cancer appearing as the primary indexed condition, and to 3 interventions - of which Blood Specimen Collection is the first listed.
NCT06633224 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06633224 about?
NCT06633224 is a clinical study titled "Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT". Cancer-related fatigue (CRF) is a significant problem for cancer patients. This prospective, basic science, observational study will evaluate for changes in CRF associated with molecular characteristics prior to, during, and at the completion of non-investigational, standard-of-care, combined chemot...
What is the current status of trial NCT06633224?
This trial is currently recruiting. The enrollment target is 125 participants. The study started on 2024-12-27. Estimated completion is 2027-09-01.
What conditions does trial NCT06633224 study?
This clinical trial studies the following conditions: Cancer, Head and Neck Cancer, Gynecologic Cancer, Gastrointestinal Cancer, Thoracic Cancer.
What interventions are being tested in trial NCT06633224?
The interventions under investigation include: Blood Specimen Collection (PROCEDURE), Stool Specimen Collection (OTHER), Quality of Life (QOL) Questionnaires (OTHER).
Who is sponsoring clinical trial NCT06633224?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06633224 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06633224's enrollment target sits among peer trials
125 286th of 615 higher than 330 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI